dexchlorpheniramine has been researched along with albendazole in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Agapejev, S; Da Silva, MD; Ueda, AK | 1 |
| Agapejev, S; Gomes, AE; Yela, DA | 1 |
1 review(s) available for dexchlorpheniramine and albendazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for dexchlorpheniramine and albendazole
| Article | Year |
|---|---|
Severe forms of neurocysticercosis: treatment with albendazole.
Topics: Adolescent; Adult; Albendazole; Anthelmintics; Brain Diseases; Chlorpheniramine; Cysticercosis; Female; Follow-Up Studies; Humans; Ketoprofen; Male; Middle Aged; Prognosis; Tomography, X-Ray Computed | 1996 |
[Chronic brain edema in neurocysticercosis].
Topics: Adult; Albendazole; Anthelmintics; Brain Edema; Chlorpheniramine; Chronic Disease; Female; Histamine H1 Antagonists; Humans; Male; Middle Aged; Neurocysticercosis; Retrospective Studies; Tomography, X-Ray Computed | 1998 |